Alfresa Holdings Corp.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$19,771
Current Liabilities (US$ Millions)$6,941
Total Assets (US$ Millions)$8,017
Long Term Debt$39
Return on Equity0.11%
Revenue (US$ Millions)$21,409
Total Company Assets$10,413
Revenue Growth (%)6.41%
Net Income (US$ Millions)$3
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$3,045
Profit Margin (%)0.02%
Debt To Equity Ratio (%)0.01%
Inventory Turnover$1,107